Islet Cell Clinical Trial Overview

Clinical Trial Qualifications
To be considered for enrollment in UW Health's islet cell clinical trial, patients must: 
  • Be between the ages of 18 and 65
  • Have poorly controlled Type 1 diabetes
  • Be ineligible for or not in favor of a standard pancreas transplant because of the associated surgical risks. 

For more information about each of our islet clinical trials, please visit the U.S. National Institute of Health website or the following links:

  • Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation (Link)
  • Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients (Link)
  • Efficacy of Islet After Kidney Transplantation (Link | Link)
  • Islet Transplantation in Type 1 Diabetic Patients (Link)
Additional Eligibility Requirements
In addition to the information above, the following is a summary of the characteristics patients must meet in order to be eligible for the islet transplant study trial: 
  • If the patient has not had a prior transplant, then he or she must have normal kidney function
  • Poorly controlled blood sugars and/or life-threatening low blood sugar events which the patient cannot anticipate
  • Body mass index less than or equal to 28
  • Absence of infection, cancer, hepatitis or HIV
  • Normal liver function